Dual targeting of Toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment.
作者信息
Kate Gadanec Laura, Qaradakhi Tawar, Renee McSweeney Kristen, Ashiana Ali Benazir, Zulli Anthony, Apostolopoulos Vasso
机构信息
Institute for Health & Sport, Victoria University, Melbourne, Australia.
出版信息
Future Microbiol. 2021 Mar;16:205-209. doi: 10.2217/fmb-2021-0018. Epub 2021 Feb 11.
Abstract
摘要
相似文献
1
Dual targeting of Toll-like receptor 4 and angiotensin-converting enzyme 2: a proposed approach to SARS-CoV-2 treatment.Toll样受体4和血管紧张素转换酶2的双重靶向：一种治疗新型冠状病毒肺炎的建议方法。
Future Microbiol. 2021 Mar;16:205-209. doi: 10.2217/fmb-2021-0018. Epub 2021 Feb 11.
2
The Two-Way Switch Role of ACE2 in the Treatment of Novel Coronavirus Pneumonia and Underlying Comorbidities.血管紧张素转换酶2（ACE2）在新型冠状病毒肺炎及基础合并症治疗中的双向开关作用
Molecules. 2020 Dec 31;26(1):142. doi: 10.3390/molecules26010142.
3
COVID-19 and Toll-Like Receptor 4 (TLR4): SARS-CoV-2 May Bind and Activate TLR4 to Increase ACE2 Expression, Facilitating Entry and Causing Hyperinflammation.COVID-19 和 Toll 样受体 4（TLR4）：SARS-CoV-2 可能结合并激活 TLR4 以增加 ACE2 的表达，从而促进进入并导致过度炎症。
Mediators Inflamm. 2021 Jan 14;2021:8874339. doi: 10.1155/2021/8874339. eCollection 2021.
4
Angiotensin-Converting-Enzyme 2 and Renin-Angiotensin System Inhibitors in COVID-19: An Update.血管紧张素转换酶 2 和肾素血管紧张素系统抑制剂在 COVID-19 中的应用：最新进展。
High Blood Press Cardiovasc Prev. 2021 Mar;28(2):129-139. doi: 10.1007/s40292-021-00439-9. Epub 2021 Feb 26.
5
The Role of Angiotensin Converting Enzyme 2 in Modulating Gut Microbiota, Intestinal Inflammation, and Coronavirus Infection.血管紧张素转化酶 2 在调节肠道微生物群、肠道炎症和冠状病毒感染中的作用。
Gastroenterology. 2021 Jan;160(1):39-46. doi: 10.1053/j.gastro.2020.07.067. Epub 2020 Oct 30.
6
Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.人类血管紧张素转换酶2（ACE2）和跨膜丝氨酸蛋白酶2（TMPRSS2）在决定新型冠状病毒肺炎（COVID-19）宿主-病原体相互作用中的作用。
J Genet. 2021;100(1). doi: 10.1007/s12041-021-01262-w.
7
Phytomedical compounds as promising therapeutic agents for COVID-19 targeting angiotensin-converting enzyme 2: a review.植物药化合物作为针对血管紧张素转换酶 2 的 COVID-19 有希望的治疗剂：综述。
J Pharm Pharmacol. 2024 Oct 3;76(10):1239-1268. doi: 10.1093/jpp/rgae101.
8
Can Antiviral Activity of Licorice Help Fight COVID-19 Infection?甘草的抗病毒活性能帮助对抗 COVID-19 感染吗？
Biomolecules. 2021 Jun 8;11(6):855. doi: 10.3390/biom11060855.
9
An angiotensin-converting enzyme-2-derived heptapeptide GK-7 for SARS-CoV-2 spike blockade.血管紧张素转换酶 2 衍生的七肽 GK-7 可阻断 SARS-CoV-2 刺突蛋白。
Peptides. 2021 Nov;145:170638. doi: 10.1016/j.peptides.2021.170638. Epub 2021 Aug 19.
10
ACE2 as a Potential Target for Management of Novel Coronavirus (nCoV- 2019).ACE2 作为新型冠状病毒（nCoV-2019）管理的潜在靶点。
Curr Drug Discov Technol. 2021;18(6):e130921189567. doi: 10.2174/1570163817999201228215911.
引用本文的文献
1
Mechanisms of endothelial activation, hypercoagulation and thrombosis in COVID-19: a link with diabetes mellitus.新型冠状病毒肺炎中血管内皮激活、高凝和血栓形成的机制：与糖尿病的关联。
Cardiovasc Diabetol. 2024 Feb 20;23(1):75. doi: 10.1186/s12933-023-02097-8.
2
Role of Angiotensin II in Cardiovascular Diseases: Introducing Bisartans as a Novel Therapy for Coronavirus 2019.血管紧张素 II 在心血管疾病中的作用：双沙坦作为 2019 年冠状病毒新型治疗方法的介绍。
Biomolecules. 2023 May 2;13(5):787. doi: 10.3390/biom13050787.
3
Computational and Enzymatic Studies of Sartans in SARS-CoV-2 Spike RBD-ACE2 Binding: The Role of Tetrazole and Perspectives as Antihypertensive and COVID-19 Therapeutics.沙坦类药物在 SARS-CoV-2 刺突 RBD-ACE2 结合中的计算和酶学研究：四唑的作用及作为抗高血压和 COVID-19 治疗药物的前景。
Int J Mol Sci. 2023 May 8;24(9):8454. doi: 10.3390/ijms24098454.
4
Molecular Epidemiology of SARS-CoV-2: The Dominant Role of Arginine in Mutations and Infectivity.SARS-CoV-2 的分子流行病学：精氨酸在突变和传染性方面的主导作用。
Viruses. 2023 Jan 22;15(2):309. doi: 10.3390/v15020309.
5
Cancer Patients during COVID-19 Pandemic: A Mini-Review.COVID-19大流行期间的癌症患者：一篇小型综述。
Healthcare (Basel). 2023 Jan 13;11(2):248. doi: 10.3390/healthcare11020248.
6
Association between the expression of toll-like receptors, cytokines, and homeostatic chemokines in SARS-CoV-2 infection and COVID-19 severity.严重急性呼吸综合征冠状病毒2感染中Toll样受体、细胞因子和稳态趋化因子的表达与冠状病毒病严重程度之间的关联
Heliyon. 2023 Jan;9(1):e12653. doi: 10.1016/j.heliyon.2022.e12653. Epub 2022 Dec 24.
7
Fast-track development of vaccines for SARS-CoV-2: The shots that saved the world.SARS-CoV-2 疫苗的快速开发：拯救世界的疫苗。
Front Immunol. 2022 Oct 3;13:961198. doi: 10.3389/fimmu.2022.961198. eCollection 2022.
8
Antiviral potential of diminazene aceturate against SARS-CoV-2 proteases using computational and in vitro approaches.使用计算和体外方法评估乙酰对氨基苯脒抗 SARS-CoV-2 蛋白酶的潜力。
Chem Biol Interact. 2022 Nov 1;367:110161. doi: 10.1016/j.cbi.2022.110161. Epub 2022 Sep 15.
9
Inhalable Vaccines: Can They Help Control Pandemics?吸入式疫苗：它们能帮助控制大流行吗？
Vaccines (Basel). 2022 Aug 13;10(8):1309. doi: 10.3390/vaccines10081309.
10
Diminazene Aceturate Reduces Angiotensin II Constriction and Interacts with the Spike Protein of Severe Acute Respiratory Syndrome Coronavirus 2.乙酰氨基阿维菌素可减轻血管紧张素 II 收缩作用并与严重急性呼吸综合征冠状病毒 2 的刺突蛋白相互作用。
Biomedicines. 2022 Jul 18;10(7):1731. doi: 10.3390/biomedicines10071731.
本文引用的文献
1
Publisher Correction: SARS-CoV-2 spike protein interacts with and activates TLR4.出版商更正：严重急性呼吸综合征冠状病毒2刺突蛋白与Toll样受体4相互作用并激活该受体
Cell Res. 2021 Jul;31(7):825. doi: 10.1038/s41422-021-00501-0.
2
Beyond Shielding: The Roles of Glycans in the SARS-CoV-2 Spike Protein.超越屏蔽作用：聚糖在新冠病毒刺突蛋白中的作用
ACS Cent Sci. 2020 Oct 28;6(10):1722-1734. doi: 10.1021/acscentsci.0c01056. Epub 2020 Sep 23.
3
SARS-CoV-2 triggers inflammatory responses and cell death through caspase-8 activation.SARS-CoV-2 通过半胱天冬酶-8 的激活引发炎症反应和细胞死亡。
Signal Transduct Target Ther. 2020 Oct 9;5(1):235. doi: 10.1038/s41392-020-00334-0.
4
COVID-19 Patients Upregulate Toll-like Receptor 4-mediated Inflammatory Signaling That Mimics Bacterial Sepsis.COVID-19 患者上调 Toll 样受体 4 介导的炎症信号，模拟细菌性败血症。
J Korean Med Sci. 2020 Sep 28;35(38):e343. doi: 10.3346/jkms.2020.35.e343.
5
Imiquimod - A toll like receptor 7 agonist - Is an ideal option for management of COVID 19.咪喹莫特 - 一种 Toll 样受体 7 激动剂 - 是治疗 COVID-19 的理想选择。
Environ Res. 2020 Sep;188:109858. doi: 10.1016/j.envres.2020.109858. Epub 2020 Jun 23.
6
Elevated Calprotectin and Abnormal Myeloid Cell Subsets Discriminate Severe from Mild COVID-19.血清钙卫蛋白和异常髓系细胞亚群可区分 COVID-19 重症与轻症。
Cell. 2020 Sep 17;182(6):1401-1418.e18. doi: 10.1016/j.cell.2020.08.002. Epub 2020 Aug 5.
7
Cardiovascular disease and COVID-19: Australian and New Zealand consensus statement.心血管疾病与 COVID-19：澳大利亚和新西兰共识声明。
Med J Aust. 2020 Aug;213(4):182-187. doi: 10.5694/mja2.50714. Epub 2020 Jul 31.
8
Activation and evasion of type I interferon responses by SARS-CoV-2.SARS-CoV-2 激活和逃避 I 型干扰素应答。
Nat Commun. 2020 Jul 30;11(1):3810. doi: 10.1038/s41467-020-17665-9.
9
Inflammation Profiling of Critically Ill Coronavirus Disease 2019 Patients.2019年冠状病毒病危重症患者的炎症谱分析
Crit Care Explor. 2020 Jun 22;2(6):e0144. doi: 10.1097/CCE.0000000000000144. eCollection 2020 Jun.
10
Single-Cell RNA Expression Profiling of ACE2, the Receptor of SARS-CoV-2.新型冠状病毒（SARS-CoV-2）受体ACE2的单细胞RNA表达谱分析
Am J Respir Crit Care Med. 2020 Sep 1;202(5):756-759. doi: 10.1164/rccm.202001-0179LE.
Zotero 插件